DOST eyes virgin coco oil as potential COVID-19 cure | Inquirer News

DOST eyes virgin coco oil as potential COVID-19 cure

/ 04:33 AM July 22, 2020

MANILA, Philippines — Many of the mild COVID-19 patients who were given virgin coconut oil (VCO) as part of a treatment trial have been sent home from the hospital, according to Secretary Fortunato dela Peña of the Department of Science and Technology (DOST).

Dela Peña said this was a “good indication,” but would need more participants to join the trial before the DOST comes to a conclusion on the matter.

ADVERTISEMENT

He said that mild COVID-19 patients who had gone home should continue taking VCO for 28 days as part of the trial.

The trial is expected to include 90 patients—45 to get the VCO, and another 45 to serve as the control group, who would be given placebo for comparison.

FEATURED STORIES

Leila B. Salaverria

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: coronavirus pandemic, coronavirus Philippines, covid-19 cure, DOST, virgin coco oil
For feedback, complaints, or inquiries, contact us.

News that matters

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.